Trader consensus prices "No" at 77.5% implied probability for a CDC Level 4 Avoid All Travel notice by December 31, reflecting the absence of any active Level 4 Travel Health Notices on the CDC's official page and stable surveillance data showing no disease with extreme, life-threatening spread. Level 4 designations require sustained high-risk transmission, as seen historically with Ebola; current threats like clade IIb mpox (over 100,000 global cases since 2022 but contained regionally), sporadic H5N1 avian influenza human infections (e.g., recent Cambodia case), and rising dengue remain at Level 2, per CDC assessments. No major escalations in the past 30 days, with low human-to-human transmission rates for novel pathogens, underpin this positioning. Traders await weekly CDC and WHO epidemiological updates, which could shift odds if case clusters surge.
Polymarket डेटा का संदर्भ देने वाला प्रयोगात्मक AI-जनरेटेड सारांश। यह ट्रेडिंग सलाह नहीं है और इस बाज़ार के समाधान में कोई भूमिका नहीं निभाता। · अपडेट किया गयासीडीसी ने 31 दिसंबर तक लेवल 4 की चेतावनी जारी कर दी है?
सीडीसी ने 31 दिसंबर तक लेवल 4 की चेतावनी जारी कर दी है?
हाँ
$71,397 वॉल्यूम
$71,397 वॉल्यूम
31 दिस, 2026
हाँ
$71,397 वॉल्यूम
$71,397 वॉल्यूम
31 दिस, 2026
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus prices "No" at 77.5% implied probability for a CDC Level 4 Avoid All Travel notice by December 31, reflecting the absence of any active Level 4 Travel Health Notices on the CDC's official page and stable surveillance data showing no disease with extreme, life-threatening spread. Level 4 designations require sustained high-risk transmission, as seen historically with Ebola; current threats like clade IIb mpox (over 100,000 global cases since 2022 but contained regionally), sporadic H5N1 avian influenza human infections (e.g., recent Cambodia case), and rising dengue remain at Level 2, per CDC assessments. No major escalations in the past 30 days, with low human-to-human transmission rates for novel pathogens, underpin this positioning. Traders await weekly CDC and WHO epidemiological updates, which could shift odds if case clusters surge.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
बाज़ार खुला: Jan 19, 2026, 3:15 PM ET
वॉल्यूम
$71,397समाप्ति तिथि
31 दिस, 2026बाज़ार खुला
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus prices "No" at 77.5% implied probability for a CDC Level 4 Avoid All Travel notice by December 31, reflecting the absence of any active Level 4 Travel Health Notices on the CDC's official page and stable surveillance data showing no disease with extreme, life-threatening spread. Level 4 designations require sustained high-risk transmission, as seen historically with Ebola; current threats like clade IIb mpox (over 100,000 global cases since 2022 but contained regionally), sporadic H5N1 avian influenza human infections (e.g., recent Cambodia case), and rising dengue remain at Level 2, per CDC assessments. No major escalations in the past 30 days, with low human-to-human transmission rates for novel pathogens, underpin this positioning. Traders await weekly CDC and WHO epidemiological updates, which could shift odds if case clusters surge.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
वॉल्यूम
$71,397समाप्ति तिथि
31 दिस, 2026बाज़ार खुला
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader consensus prices "No" at 77.5% implied probability for a CDC Level 4 Avoid All Travel notice by December 31, reflecting the absence of any active Level 4 Travel Health Notices on the CDC's official page and stable surveillance data showing no disease with extreme, life-threatening spread. Level 4 designations require sustained high-risk transmission, as seen historically with Ebola; current threats like clade IIb mpox (over 100,000 global cases since 2022 but contained regionally), sporadic H5N1 avian influenza human infections (e.g., recent Cambodia case), and rising dengue remain at Level 2, per CDC assessments. No major escalations in the past 30 days, with low human-to-human transmission rates for novel pathogens, underpin this positioning. Traders await weekly CDC and WHO epidemiological updates, which could shift odds if case clusters surge.
Polymarket डेटा का संदर्भ देने वाला प्रयोगात्मक AI-जनरेटेड सारांश। यह ट्रेडिंग सलाह नहीं है और इस बाज़ार के समाधान में कोई भूमिका नहीं निभाता। · अपडेट किया गया
बाहरी लिंक से सावधान रहें।
बाहरी लिंक से सावधान रहें।
अक्सर पूछे जाने वाले प्रश्न